Global Molecular Diagnostics Market, By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026

September 2021 | 111 pages | ID: G89DD9D3EC03EN
TechSci Research

Abstracts

Global molecular diagnostics market is projected to reach USD80.45 billion by 2026, growing at CAGR of 2.98% through 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19. The market growth can be attributed to large outbreaks of bacterial and viral epidemics in the world, increasing demand for Point-of-Care (PoC) diagnostics, recent advancements in pharmacogenomics and rapidly evolving technologies in the field of genetic research and engineering are expected to drive the growth of the market in the coming five years. Moreover, rising instances of infectious diseases in the world are also driving the molecular diagnostic department to find the efficient and effective treatment and therapeutics for the diseases thereby sustaining the growth of the market in the next five years. Furthermore, the governments are actively aiding the research and development sector in the molecular diagnostics financially which can be attributed as the major factor for the market growth.

Rising instances of unpredictable pathogens and changing lifestyles has given birth to diseases that were unknown. Recent example of COVID-19 virus has driven the governments, as well as the consumers and market players towards the need of research and development for the treatment and therapeutic plans for the infectious, and chronic diseases. Genetic mutations due to environmental factors, radiation and various other factors are increasing, causing deformed birth of human population, thereby driving the growth of the market.

The global molecular diagnostics market is segmented into products & services, technology, application, end user, regional distribution, and competitional landscape. Based on technology the market is further bifurcated into Polymerase Chain Reaction (PCR), sequencing, in-situ hybridization, chips and microarrays, mass spectrometry and others. Polymerase chain reaction (PCR) is anticipated to hold the largest market share in the next five years on the account of its use in the detection of infectious microorganisms such as viruses and bacteria. Polymerase chain reaction is a method of multiplication of the genetic material to reach billions of the copies. The method allows the scientists to study the DNA, RNA, or other genetic material sample after the specific gene or segment of the genetic material is amplified. The method uses the ability of the genetic material to multiply and rapidly increase the process in order to obtain a large amount in much smaller span of time.

Major companies operating in the global molecular diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories Ltd., Danaher Corporation, Siemens Healthineers AG, Hologic Inc. (Gen Probe), Illumina Inc., Grifols S.A., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Becton, Dickinson and Company Ltd., Myriad Genetics Inc., Johnson & Johnson Services, Inc., bioM?rieux SA, among others.

Years considered for this report:

• Historical Years: 2016 – 2019
• Base Year: 2020
• Estimated Year: 2021
• Forecast Period: 2022 – 2026

Objective of the Study:

• To analyze the historical growth in the market size of the global molecular diagnostics market from 2016 to 2020.
• To estimate and forecast the market size of the global molecular diagnostics market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast the global molecular diagnostics market based on products & services, technology, application, end user, regional distribution, and competitional landscape.
• To identify dominant region or segment in the global molecular diagnostics market.
• To identify drivers and challenges for the global molecular diagnostics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global molecular diagnostics market.
• To identify and analyze the profile of leading players operating in the global molecular diagnostics market.
• To identify key sustainable strategies adopted by market players in the global molecular diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers globally. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global molecular diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Manufacturers, end users and other stakeholders
• Distributors and suppliers of kits, reagents and assays and other stakeholders
• Organizations, forums and alliances related to molecular diagnostics
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global molecular diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Global Molecular Diagnostics Market, By Products and Services:
• Reagents and Kits
• Instruments
• Services and Software
• Global Molecular Diagnostics Market, By Technology:
• Polymerase Chain Reaction (PCR)
• Sequencing
• In-situ hybridization
• Chips and microarrays
• Mass spectrometry
• Others
• Global Molecular Diagnostics Market, By Application:
• Infectious disease
• Oncology Testing
• Genetic Testing
• Blood Screening
• Others
• Global Molecular Diagnostics Market, By End User:
• Hospitals
• Academic & Reference Laboratories
• Others
• Global Molecular Diagnostics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Germany
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global molecular diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL MOLECULAR DIAGNOSTICS MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

5.1. Factors Driving the Molecular Diagnostics Market
5.2. Brand Awareness
5.3. Customer Satisfaction Analysis

6. GLOBAL MOLECULAR DIAGNOSTICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Products and Services (Reagents and Kits, Instruments, Services and Software)
  6.2.2. By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others)
  6.2.3. By Application (Infectious disease, Oncology testing, Genetic testing, Blood Screening, Others)
  6.2.4. By End User (Hospitals, Academic & Reference Laboratories, Others)
  6.2.5. By Company (2020)
  6.2.6. By Region
6.3. Product Market Map

7. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Products and Services
  7.2.2. By Technology
  7.2.3. By Application
  7.2.4. By End User
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Molecular Diagnostics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Products and Services
      7.3.1.2.2. By Technology
      7.3.1.2.3. By Application
      7.3.1.2.4. By End User
  7.3.2. Canada Molecular Diagnostics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Products and Services
      7.3.2.2.2. By Technology
      7.3.2.2.3. By Application
      7.3.2.2.4. By End User
  7.3.3. Mexico Molecular Diagnostics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Products and Services
      7.3.3.2.2. By Technology
      7.3.3.2.3. By Application
      7.3.3.2.4. By End User

8. EUROPE MOLECULAR DIAGNOSTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Products and Services
  8.2.2. By Technology
  8.2.3. By Application
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France Molecular Diagnostics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Products and Services
      8.3.1.2.2. By Technology
      8.3.1.2.3. By Application
      8.3.1.2.4. By End User
  8.3.2. United Kingdom Molecular Diagnostics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Products and Services
      8.3.2.2.2. By Technology
      8.3.2.2.3. By Application
      8.3.2.2.4. By End User
  8.3.3. Germany Molecular Diagnostics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Products and Services
      8.3.3.2.2. By Technology
      8.3.3.2.3. By Application
      8.3.3.2.4. By End User
  8.3.4. Italy Molecular Diagnostics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Products and Services
      8.3.4.2.2. By Technology
      8.3.4.2.3. By Application
      8.3.4.2.4. By End User
  8.3.5. Spain Molecular Diagnostics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Products and Services
      8.3.5.2.2. By Technology
      8.3.5.2.3. By Application
      8.3.5.2.4. By End User

9. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Products and Services
  9.2.2. By Technology
  9.2.3. By Application
  9.2.4. By End User
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Molecular Diagnostics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Products and Services
      9.3.1.2.2. By Technology
      9.3.1.2.3. By Application
      9.3.1.2.4. By End User
  9.3.2. Japan Molecular Diagnostics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Products and Services
      9.3.2.2.2. By Technology
      9.3.2.2.3. By Application
      9.3.2.2.4. By End User
  9.3.3. India Molecular Diagnostics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Products and Services
      9.3.3.2.2. By Technology
      9.3.3.2.3. By Application
      9.3.3.2.4. By End User
  9.3.4. Australia Molecular Diagnostics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Products and Services
      9.3.4.2.2. By Technology
      9.3.4.2.3. By Application
      9.3.4.2.4. By End User
  9.3.5. South Korea Molecular Diagnostics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Products and Services
      9.3.5.2.2. By Technology
      9.3.5.2.3. By Application
      9.3.5.2.4. By End User
  9.3.6. Singapore Molecular Diagnostics Market Outlook
    9.3.6.1. Market Size & Forecast
      9.3.6.1.1. By Value
    9.3.6.2. Market Share & Forecast
      9.3.6.2.1. By Products and Services
      9.3.6.2.2. By Technology
      9.3.6.2.3. By Application
      9.3.6.2.4. By End User

10. SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Products and Services
  10.2.2. By Technology
  10.2.3. By Application
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Molecular Diagnostics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Products and Services
      10.3.1.2.2. By Technology
      10.3.1.2.3. By Application
      10.3.1.2.4. By End User
  10.3.2. Argentina Molecular Diagnostics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Products and Services
      10.3.2.2.2. By Technology
      10.3.2.2.3. By Application
      10.3.2.2.4. By End User
  10.3.3. Colombia Molecular Diagnostics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Products and Services
      10.3.3.2.2. By Technology
      10.3.3.2.3. By Application
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Products and Services
  11.2.2. By Technology
  11.2.3. By Application
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Molecular Diagnostics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Products and Services
      11.3.1.2.2. By Technology
      11.3.1.2.3. By Application
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia Molecular Diagnostics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Products and Services
      11.3.2.2.2. By Technology
      11.3.2.2.3. By Application
      11.3.2.2.4. By End User
  11.3.3. UAE Molecular Diagnostics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Products and Services
      11.3.3.2.2. By Technology
      11.3.3.2.3. By Application
      11.3.3.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Competition Outlook
14.2. Players Profiled
  14.2.1. F. Hoffmann-La Roche Ltd.
  14.2.2. Abbott Laboratories Ltd.
  14.2.3. Danaher Corporation
  14.2.4. Siemens Healthineers AG
  14.2.5. Hologic Inc. (Gen Probe)
  14.2.6. Illumina Inc.
  14.2.7. Grifols S.A.
  14.2.8. Bio-Rad Laboratories Inc.
  14.2.9. Agilent Technologies Inc.
  14.2.10. Thermo Fisher Scientific Inc.
  14.2.11. Qiagen N.V.
  14.2.12. Becton, Dickinson and Company Ltd.
  14.2.13. Myriad Genetics Inc.
  14.2.14. Johnson & Johnson Services, Inc.
  14.2.15. bioM?rieux SA

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

List Of Figures

LIST OF FIGURES

Figure 1: Global Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 3: Global Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 4: Global Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 5: Global Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 6: Global Molecular Diagnostics Market Share, By Company, By Value, 2020
Figure 7: Global Molecular Diagnostics Market Share, By Region, By Value, 2016-2026F
Figure 8: Global Molecular Diagnostics Product Market Map, By Value, 2016-2026F
Figure 9: North America Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 10: North America Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 11: North America Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 12: North America Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 13: North America Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 14: North America Molecular Diagnostics Market Share, By Country, By Value, 2020
Figure 15: United States Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 16: United States Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 17: United States Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 18: United States Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 19: United States Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 20: Canada Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 21: Canada Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 22: Canada Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 23: Canada Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 24: Canada Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 25: Mexico Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 26: Mexico Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 27: Mexico Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 28: Mexico Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 29: Mexico Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 30: Europe Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 31: Europe Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 32: Europe Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 33: Europe Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 34: Europe Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 35: Europe Molecular Diagnostics Market Share, By Country, By Value, 2020
Figure 36: France Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 37: France Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 38: France Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 39: France Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 40: France Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 41: United Kingdom Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 42: United Kingdom Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 43: United Kingdom Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 44: United Kingdom Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 45: United Kingdom Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 46: Germany Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 47: Germany Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 48: Germany Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 49: Germany Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 50: Germany Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 51: Italy Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 52: Italy Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 53: Italy Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 54: Italy Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 55: Italy Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 56: Spain Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 57: Spain Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 58: Spain Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 59: Spain Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 60: Spain Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 61: Asia-Pacific Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 62: Asia-Pacific Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 63: Asia-Pacific Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 64: Asia-Pacific Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 65: Asia-Pacific Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 66: Asia-Pacific Molecular Diagnostics Market Share, By Country, By Value, 2020
Figure 67: China Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 68: China Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 69: China Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 70: China Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 71: China Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 72: Japan Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 73: Japan Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 74: Japan Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 75: Japan Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 76: Japan Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 77: India Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 78: India Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 79: India Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 80: India Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 81: India Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 82: Australia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 83: Australia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 84: Australia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 85: Australia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 86: Australia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 87: South Korea Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 88: South Korea Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 89: South Korea Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 90: South Korea Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 91: South Korea Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 92: Singapore Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 93: Singapore Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 94: Singapore Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 95: Singapore Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 96: Singapore Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 97: South America Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 98: South America Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 99: South America Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 100: South America Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 101: South America Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 102: South America Molecular Diagnostics Market Share, By Country, By Value, 2020
Figure 103: Brazil Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 104: Brazil Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 105: Brazil Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 106: Brazil Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 107: Brazil Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 108: Argentina Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 109: Argentina Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 110: Argentina Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 111: Argentina Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 112: Argentina Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 113: Colombia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 114: Colombia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 115: Colombia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 116: Colombia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 117: Colombia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 118: Middle East and Africa Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 119: Middle East and Africa Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 120: Middle East and Africa Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 121: Middle East and Africa Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 122: Middle East and Africa Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 123: Middle East and Africa Molecular Diagnostics Market Share, By Country, By Value, 2020
Figure 124: South Africa Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 125: South Africa Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 126: South Africa Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 127: South Africa Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 128: South Africa Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 129: Saudi Arabia Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 130: Saudi Arabia Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 131: Saudi Arabia Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 132: Saudi Arabia Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 133: Saudi Arabia Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 134: UAE Molecular Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 135: UAE Molecular Diagnostics Market Share, By Products and Services, By Value, 2016-2026F
Figure 136: UAE Molecular Diagnostics Market Share, By Technology, By Value, 2016-2026F
Figure 137: UAE Molecular Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 138: UAE Molecular Diagnostics Market Share, By End User, By Value, 2016-2026F